The Life Sciences Open Innovation Day brings together leaders from academia and industry (e.g. academic/clinical scientists, biotech & pharma, CROs, SMEs, etc.) to discuss current challenges and develop new concepts for an ecosystem fostering open science and innovation. In this ecosystem of public-private partnerships, members from academia, industry, and society connect, share perspectives, and directly collaborate on high-impact research and development of projects with defined outcomes tangible in the public sphere.
The specialization of scientific researchers has been essential for developing expertise in many individual fields comprising the biomedical landscape, but the resulting culture of specialty silos has diminished cross-disciplinary collaborations, which are crucial for addressing complex problems that directly impact societal stakeholders. As a consequence, the recognition and trust of the public towards scientists has diminished, research funding has stagnated, while pressing issues in medicine remain unresolved.
To tackle these issues and find solutions, this year’s Open Innovation Day will comprise alternating keynote lectures and expert panel discussions about the following two topics:
- Benefits of open science and the way scientific research should be evaluated?
- What are current biomedical, ethical, and societal challenges for precision medicine?